Menu

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
aberenguera@idiapjgol.org
avatar_grups_recerca.png

Projects

Group projects

APP FARMACS EMBARAS

  • Principal investigators: Maria Giner Soriano
  • Code: 9F-0-00021-25
  • Start year: 2025

Post-authorisation safety study to evaluate the utilisation and safety of atogepant in patients with migraine and significant cardiovascular and/or cerebrovascular disease in European countries

  • Principal investigators: Talita Duarte Salles
  • Code: 4RNC-0-00113-24
  • Start year: 2025
  • Funders: Pharmo Institute N.V.

Atlas de prescripción farmacéutica en Diabetes

  • Principal investigators: Anna Moleras Serra, Anna Berenguera Ossó
  • Code: 4RNC-0-00238-24
  • Start year: 2025

Atlas para la monitorización de los cuidados en Diabetes

  • Principal investigators: Anna Moleras Serra, Anna Berenguera Ossó
  • Code: 4RNC-0-00270-24
  • Start year: 2025

TARGET EU – Comparative effectiveness and safety studies using the target trial emulation and estimand frameworks: Rivaroxaban and risk of major gastrointestinal bleeding in elderly patients with non-valvular atrial fibrillation (version 0.3, 10 November 2025)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00338-25
  • Start year: 2025

Board of Trustees

Collaborators

Accreditations